Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by Alfonsou

Order by:

XWEL	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
TCEHY	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
XWEL	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 15, 2022
TCEHY	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 15, 2022
TCEHY	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
XWEL	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
XWEL	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 2, 2022
TCEHY	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 2, 2022
TCEHY	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 11, 2022
XWEL	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 11, 2022
TCEHY	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... May 3, 2022
XWEL	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 30, 2022
TCEHY	"Julia Levy Award" Recipient David Allan and Dr. John McGraw FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John... April 26, 2022

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Voyageur Pharmaceuticals Ltd V.VM

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical ... view more »